Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
about
Hepatic consequences of vascular adhesion protein-1 expressionDysregulated hepatic expression of glucose transporters in chronic disease: contribution of semicarbazide-sensitive amine oxidase to hepatic glucose uptakeChange in vascular adhesion protein-1 and metabolic phenotypes after vertical banded gastroplasty for morbid obesityVascular adhesion protein-1 in human ischaemic strokeSerum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetesVascular adhesion protein-1 in hemodialysis and hemodiafiltration patients: effect of single hemodialysis session on its level in regard to type of anticoagulantVascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosisAmine oxidase substrates for impaired glucose tolerance correction.Biomarkers for type 1 diabetes.Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1: a patent survey.Effects of pioglitazone and vildagliptin on coagulation cascade in diabetes mellitus--targeting thrombogenesis.Semicarbazide-sensitive amine oxidase and kidney disease.Vascular adhesion protein-1: Role in human pathology and application as a biomarker.Crystallization of a truncated soluble human semicarbazide-sensitive amine oxidase.Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients.The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner.Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats.Vascular adhesion protein-1 and syndecan-1 in septic shock.Medical implications from the crystal structure of a copper-containing amine oxidase complexed with the antidepressant drug tranylcypromine.Serum vascular adhesion protein-1 level is higher in smokers than non-smokers.Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.Oleanolic acid protects against oxidative stress‑induced human umbilical vein endothelial cell injury by activating AKT/eNOS signaling
P2860
Q28236182-CC6ECCF4-21A1-4CF2-9547-172B716E137FQ28250220-DF15D97C-128F-43ED-913A-F86F2243C58FQ28253116-D519DB5C-0690-4461-AF35-361A37E7040DQ28257436-57588754-9D6A-4614-83BB-690531A2E0F7Q28304388-C8B015F6-86B7-4F46-B6F3-C1EF8C79F65EQ33599915-F572F01E-8E78-4E0C-ABC7-B4716A9C80BFQ35056710-F08957C5-B61D-46BF-8DE9-635871390330Q36265726-2C5BB4EF-05D3-4330-9728-4A19FAE574BCQ37000150-99BD26E3-2302-4B23-BFE0-49626FB9B9EEQ37889987-CF42DF8D-9D57-4282-8EB9-0CB18236930BQ38077284-7CC8DDC1-4955-44B2-B239-7CBC004A166AQ38156644-4488CC26-C169-45B3-835E-A4A1FDC53D74Q38569377-F536AC2B-EE22-447F-88F2-F62EDD426173Q40309705-A961307B-2F85-49D1-A6CA-91B1F4779AAAQ41558737-F6ED6B1D-E403-4A78-8890-937913975239Q42686515-17B33D75-321E-4300-98B9-E654441BD8D4Q42809919-A187DF4F-38F7-4FDA-8B90-0CA6BA5298B1Q42831410-AD20DDD1-540D-4CF1-8015-FDC7DE000348Q44923040-999327EC-83DE-421C-8C80-E3613F1DB5BEQ45021935-4641B2DA-CD28-4038-91B8-DE822B529CC8Q45118969-C0ABB7AF-F3CA-451D-8A13-43B2B347ADA7Q46517140-4F9C3FE3-F74F-4125-B87E-9AC39302BCE9Q46944958-FB144E8F-2365-4D9A-95AF-577BA94B8E50Q50069408-BF7D4559-1502-41C1-A3FC-890F05230765Q58800902-78C37774-26CD-43A6-BD62-C27A9746C5B3
P2860
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@ast
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@en
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@nl
type
label
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@ast
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@en
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@nl
prefLabel
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@ast
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@en
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@nl
P2093
P2860
P1476
Insulin-regulated increase of soluble vascular adhesion protein-1 in diabetes
@en
P2093
Craig Stolen
Gennady G Yegutkin
Marko Salmi
Pekka Jousilahti
Päivi Tapanainen
Sirpa Jalkanen
Tuula Janatuinen
P2860
P304
P356
10.1016/S0002-9440(10)64501-4
P407
P577
2002-12-01T00:00:00Z